|
ZNF107 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.2475999999978E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.698900E-03 |
| Normal-vs-Stage2 |
3.606400E-02 |
| Normal-vs-Stage3 |
2.314200E-01 |
| Normal-vs-Stage4 |
2.829400E-01 |
| Stage1-vs-Stage2 |
2.907000E-01 |
| Stage1-vs-Stage3 |
4.311000E-01 |
| Stage1-vs-Stage4 |
8.830400E-01 |
| Stage2-vs-Stage3 |
1.598610E-01 |
| Stage2-vs-Stage4 |
5.518600E-01 |
| Stage3-vs-Stage4 |
5.558000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.362900E-04 |
| Normal-vs-AfricanAmerican |
3.380900E-03 |
| Normal-vs-Asian |
8.955900E-02 |
| Caucasian-vs-AfricanAmerican |
5.110800E-01 |
| Caucasian-vs-Asian |
1.347000E-01 |
| AfricanAmerican-vs-Asian |
2.599800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.571700E-04 |
| Normal-vs-Female |
4.409100E-04 |
| Male-vs-Female |
3.006600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.308100E-02 |
| Normal-vs-Extreme_Weight |
6.020000E-02 |
| Normal-vs-Obese |
1.616410E-03 |
| Normal-vs-Extreme_Obese |
2.091600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.618400E-01 |
| Normal_Weight-vs-Obese |
3.377800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.226200E-01 |
| Extreme_Weight-vs-Obese |
9.793800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.079400E-01 |
| Obese-vs-Extreme_Obese |
7.310800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.525000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.76908999999226E-05 |
| Normal-vs-Age(61-80Yrs) |
5.395500E-03 |
| Normal-vs-Age(81-100Yrs) |
8.480800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.547000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.358200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.704500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.162620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.165900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.918420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.10419999999056E-06 |
| Normal-VS-Type2 PRCC |
8.909400E-01 |
| Normal-VS-KIRP CIMP |
2.628600E-01 |
| Normal-VS-Unclassified PRCC |
6.421100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.73089999999654E-05 |
| Type1 PRCC-VS-KIRP CIMP |
5.278100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.715600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.276800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.222700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.136210E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.930400E-01 |
| Normal-vs-N1 |
1.746340E-02 |
| Normal-vs-N2 |
4.180000E-01 |
| N0-vs-N1 |
5.266200E-02 |
| N0-vs-N2 |
3.902600E-01 |
| N1-vs-N2 |
6.199100E-03 |
|
|
